ありがとうございました！
あなたの情報は私たちのチームに送信され、まもなくフォローアップメールが届きます。
For many cancer patients who die from this awful disease, their tumors aren’t solely responsible. In many instances, superbugs sicken these patients, who can’t fight off resistant infections due to weakened immune systems — even with the help of antibiotics.
Bringing New Data to Light
To fight the threat of antimicrobial resistance (AMR) in cancer patients, the Cancer & AMR Consortium was formed. Our goal is to bring new data to light about the link between AMR and cancer. Here are some of the findings:
Compared to non-cancer patients, hospitalized cancer patients had nearly 1.5-2x antimicrobial resistance in certain key pathogens1
Out of the >5.2 Million Patient Admissions in the U.S., >300,000 are cancer patients1
Bacteria that is highly resistant to the strongest antibiotics are more likely to be found in cancer vs. non-cancer patients1
One study found significantly higher rates of AMR in the cancer group compared to the non-cancer group across most bacteria sample types1
Turning Knowledge Into Action
Antibiotics are a critical tool in cancer care. It’s important to make sure clinicians today can still prevent and treat drug-resistant infections while new antibiotics are being developed.
- Policymakers should make necessary reforms to ensure better treatments and diagnostics are available in the future
- Healthcare professionals should improve the use of diagnostics and antibiotics through stewardship and infection prevention efforts
- The cancer community can advocate for a reduction in AMR rates and for better access to antibiotics
Contact us to learn more and work with consortium
Learn more about Cancer & AMR.
If you have time, listen to the Cancer and AMR podcasts
What You Can Do
Understanding how AMR impacts modern medicine requires more research. Here are ways you can help take action today:
For Patients
If you are going through cancer treatment, information is power. The first step to protecting yourself is by understanding antimicrobial resistance.
For Clinicians and Researchers
If you work on the frontlines, you may be seeing firsthand how the rise of AMR impacts treatment for a spectrum of diseases. Learn how to help improve our understanding of AMR and cancer.
For the Public
Raising awareness of AMR and its link to cancer care is critical to driving change. Learn why AMR is now a global threat and how you can help ensure our leaders are taking this seriously.
For the Media
AMR is a complex story. As journalists and other members of the media, you are essential to conveying the threat it poses to cancer patients and modern medicine at large.
References
- Gupta, V. Burden of Antimicrobial Resistance in Hospitalized Patients with Cancer: A Multicenter Analysis. Poster presented at: ASM-ESCMID 2023 Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance (ASM-ESCMID) 19 – 22 September 2023 ï Boston, MA USA.